Market Cap N/A
Revenue (ttm) 25.51B
Net Income (ttm) 1.20B
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 4.70%
Debt to Equity Ratio 127.26
Volume 17,987,801
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-f...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 847 949 5500
Address:
3 Lakes Drive, Northfield, United States
cryptictruth
cryptictruth Jun. 4 at 12:23 PM
$MDLN trash stock
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 10:58 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 9:41 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 8:07 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 3 at 11:23 PM
0 · Reply
chartistmind
chartistmind Jun. 3 at 8:04 PM
0 · Reply
notreload_ai
notreload_ai Jun. 2 at 7:54 PM
FDA warning letter to $MDLN over repeated Bacillus cereus contamination and poor investigations at its Illinois plant. Shares slide 8%, but Baird says financial impact is “not material.” https://notreload.xyz/xy/fda-warning-letter-hits-medline-baird-downplays-impact/
1 · Reply
PhotonicDigger
PhotonicDigger Jun. 2 at 7:41 PM
$MDLN FDA inspected Medline’s Waukegan facility from Oct 6-14, 2025. Significant CGMP violations found for drug manufacturing. Medline’s methods, facilities, or controls didn’t meet regulations, making products technically adulterated. Response acknowledged by FDA.
0 · Reply
chartistmind
chartistmind Jun. 2 at 6:31 PM
$MDLN wtf, gobbled
0 · Reply
ChickenLOVEACDC
ChickenLOVEACDC Jun. 2 at 5:10 PM
$MDLN I close at 33.5 at a small loss. I thought it can form a bull flag but it breaks down lower well glad only a small position
0 · Reply
Latest News on MDLN
Medline price target lowered to $45 from $57 at Baird

2026-06-03T11:10:04.000Z - 1 day ago

Medline price target lowered to $45 from $57 at Baird


Medline price target lowered to $45 from $50 at Barclays

2026-06-01T10:17:30.000Z - 3 days ago

Medline price target lowered to $45 from $50 at Barclays


Medline's Prime Vendor model expands outside the United States

May 29, 2026, 10:25 AM EDT - 6 days ago

Medline's Prime Vendor model expands outside the United States


Medline 72.6M share Secondary priced at $37.00

2026-05-22T10:32:12.000Z - 13 days ago

Medline 72.6M share Secondary priced at $37.00


Medline Registration statement: Registration filing

May 20, 2026, 8:00 AM EDT - 15 days ago

Medline Registration statement: Registration filing


Medline price target lowered to $42 from $48 at Deutsche Bank

2026-05-07T20:32:27.000Z - 27 days ago

Medline price target lowered to $42 from $48 at Deutsche Bank


Medline price target lowered to $54 from $56 at Bernstein

2026-05-07T16:55:21.000Z - 4 weeks ago

Medline price target lowered to $54 from $56 at Bernstein


Medline price target lowered to $55 from $60 at Citi

2026-05-07T11:18:27.000Z - 4 weeks ago

Medline price target lowered to $55 from $60 at Citi


Medline reports Q1 adjusted EPS 33c, consensus 29c

2026-05-07T03:46:11.000Z - 4 weeks ago

Medline reports Q1 adjusted EPS 33c, consensus 29c


Medline backs FY26 adjusted EBITDA view $3.5B-$3.6B

2026-05-07T03:44:17.000Z - 4 weeks ago

Medline backs FY26 adjusted EBITDA view $3.5B-$3.6B


Medline issued recall of all neuro sponge products, FDA says

2026-05-07T02:53:09.000Z - 4 weeks ago

Medline issued recall of all neuro sponge products, FDA says


Medline Earnings Call Transcript: Q1 2026

May 6, 2026, 9:30 AM EDT - 4 weeks ago

Medline Earnings Call Transcript: Q1 2026


Medline Earnings release: Q1 2026

May 6, 2026, 9:30 AM EDT - 4 weeks ago

Medline Earnings release: Q1 2026


Medline Slides: Q1 2026

May 6, 2026, 9:30 AM EDT - 4 weeks ago

Medline Slides: Q1 2026


Medline Quarterly report: Q1 2026

May 6, 2026, 9:30 AM EDT - 4 weeks ago

Medline Quarterly report: Q1 2026


Medline Reports First Quarter 2026 Results

May 6, 2026, 7:30 AM EDT - 4 weeks ago

Medline Reports First Quarter 2026 Results


Medline Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 6 weeks ago

Medline Proxy statement: Proxy filing


Medline Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 6 weeks ago

Medline Proxy statement: Proxy filing


US FDA warns Medline over defective heart procedure syringes

Apr 8, 2026, 9:22 AM EDT - 2 months ago

US FDA warns Medline over defective heart procedure syringes


Medline to report first quarter 2026 results on May 6, 2026

Apr 8, 2026, 9:00 AM EDT - 2 months ago

Medline to report first quarter 2026 results on May 6, 2026


Medline Awards Distribution Center of the Year and SAFE Awards

Mar 9, 2026, 11:47 AM EDT - 3 months ago

Medline Awards Distribution Center of the Year and SAFE Awards


Medline Registration statement: Registration Filing

Mar 3, 2026, 7:00 AM EST - 3 months ago

Medline Registration statement: Registration Filing


Medline Earnings Call Transcript: Q4 2025

Feb 25, 2026, 9:30 AM EST - 3 months ago

Medline Earnings Call Transcript: Q4 2025


Medline Annual report: Q4 2025

Feb 25, 2026, 9:30 AM EST - 3 months ago

Medline Annual report: Q4 2025


Medline Earnings release: Q4 2025

Feb 25, 2026, 9:30 AM EST - 3 months ago

Medline Earnings release: Q4 2025


Medline Slides: Q4 2025

Feb 25, 2026, 9:30 AM EST - 3 months ago

Medline Slides: Q4 2025


Medline Reports Fourth Quarter and Full Year 2025 Results

Feb 25, 2026, 7:30 AM EST - 3 months ago

Medline Reports Fourth Quarter and Full Year 2025 Results


Medline opens at $35, above IPO price of $29

Dec 17, 2025, 2:13 PM EST - 6 months ago

Medline opens at $35, above IPO price of $29


Medline Stock Jumps About 29% Following Year's Largest IPO

Dec 17, 2025, 2:05 PM EST - 6 months ago

Medline Stock Jumps About 29% Following Year's Largest IPO


Medical supply firm Medline set to debut after biggest IPO of 2025

Dec 17, 2025, 12:10 PM EST - 6 months ago

Medical supply firm Medline set to debut after biggest IPO of 2025


Medline stock debuts at $29: what investors should watch after IPO

Dec 17, 2025, 11:08 AM EST - 6 months ago

Medline stock debuts at $29: what investors should watch after IPO


Medline set for hotly anticipated debut after 2025's biggest IPO

Dec 17, 2025, 6:37 AM EST - 6 months ago

Medline set for hotly anticipated debut after 2025's biggest IPO


Medline Announces Pricing of Upsized Initial Public Offering

Dec 16, 2025, 6:00 PM EST - 6 months ago

Medline Announces Pricing of Upsized Initial Public Offering


cryptictruth
cryptictruth Jun. 4 at 12:23 PM
$MDLN trash stock
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 10:58 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 9:41 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 8:07 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 3 at 11:23 PM
0 · Reply
chartistmind
chartistmind Jun. 3 at 8:04 PM
0 · Reply
notreload_ai
notreload_ai Jun. 2 at 7:54 PM
FDA warning letter to $MDLN over repeated Bacillus cereus contamination and poor investigations at its Illinois plant. Shares slide 8%, but Baird says financial impact is “not material.” https://notreload.xyz/xy/fda-warning-letter-hits-medline-baird-downplays-impact/
1 · Reply
PhotonicDigger
PhotonicDigger Jun. 2 at 7:41 PM
$MDLN FDA inspected Medline’s Waukegan facility from Oct 6-14, 2025. Significant CGMP violations found for drug manufacturing. Medline’s methods, facilities, or controls didn’t meet regulations, making products technically adulterated. Response acknowledged by FDA.
0 · Reply
chartistmind
chartistmind Jun. 2 at 6:31 PM
$MDLN wtf, gobbled
0 · Reply
ChickenLOVEACDC
ChickenLOVEACDC Jun. 2 at 5:10 PM
$MDLN I close at 33.5 at a small loss. I thought it can form a bull flag but it breaks down lower well glad only a small position
0 · Reply
michael23
michael23 Jun. 2 at 2:33 PM
$MDLN That secondaey gave retail a opptunity to scale in lower
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Jun. 1 at 10:50 PM
$MDLN I’m already so deep with over 70k invested into this stock. Not sure if I should keep DCA down or just wait. I don’t want to have too much of my portfolio in a stock.
1 · Reply
chartistmind
chartistmind Jun. 1 at 3:32 PM
$MDLN stinking garbage. Added
0 · Reply
ZZZZniiiiight
ZZZZniiiiight May. 31 at 5:27 AM
$MDLN how we all feeling about this right now? I have 1,400 shares and will be holding for 5-10 years but wanted to get others options for long term holding.
1 · Reply
AXLFI_HQ
AXLFI_HQ May. 29 at 2:04 PM
$MDLN Large-cap companies access debt and equity markets at favorable rates while smaller and growth-stage companies face elevated borrowing costs, equity dilution, and listing compliance pressures, widening competitive advantages. Learn more: https://axlfi.com/themes/289
0 · Reply
SuperGreenToday
SuperGreenToday May. 26 at 9:57 PM
$MDLN Share Price: $36.15 Contract Selected: Nov 20, 2026 $35 Calls Buy Zone: $3.91 – $4.83 Target Zone: $6.89 – $8.42 Potential Upside: 66% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
cryptictruth
cryptictruth May. 26 at 5:33 PM
$MDLN feels like when I worked for them wage theft has turned in to share holder theft…
1 · Reply
BillionerOfKing
BillionerOfKing May. 25 at 7:39 PM
$MDLN Current Stock Price: $37.02 Contracts to trade: $35.0 MDLN Jun 18 2026 Call Entry: $2.75 Exit: $5.16 ROI: 87% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Docstocks27
Docstocks27 May. 23 at 1:36 AM
$MDLN is no one worried about the lockup expiring?
1 · Reply
AlertsAndNews
AlertsAndNews May. 22 at 2:55 AM
$MDLN Medline Inc. announces pricing of upsized secondary offering of Class A common stock "announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share"
0 · Reply
theobserver101
theobserver101 May. 21 at 4:17 AM
$SYM Based on the most followed narrative, Symbotic’s fair value of $64.05 sits well above the latest close at $46.61 The acceleration of global e commerce adoption and the resulting push for retailers and wholesalers to overtake legacy distribution models with automation is fueling strong demand for Symbotic's advanced warehouse systems. This is evidenced by their record $22.4b backlog and expanding inbound pipeline, which supports long term revenue growth. $WMT $MDLN are just to of the publicly traded companies they are handling fulfillment for
2 · Reply
quotient
quotient May. 20 at 10:42 PM
$MDLN What is the secondary offering priced at? Has that been announced?
1 · Reply